Replimune Group (REPL) Earnings Date, Estimates & Call Transcripts $14.93 +3.88 (+35.11%) (As of 11/22/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Replimune Group Latest Earnings SummaryUpcoming Earnings DateFeb. 13EstimatedActual EPS (Nov. 12) -$0.68 Beat By $0.07 Consensus EPS (Nov. 12) -$0.75 Replimune Group posted Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.68, which topped analysts' consensus estimates of -$0.75 by $0.07. With a trailing EPS of -$3.05, Replimune Group's earnings are expected to grow next year, from ($3.02) to ($2.54) per share. REPL Upcoming EarningsReplimune Group's next earnings date is estimated for Thursday, February 13, 2025, based off prior year's reporting schedules. Get Replimune Group Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Replimune Group and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataREPL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.REPL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Insiders Exposed917 Trades… Zero Losses?As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Replimune Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.87-$0.80-$0.84Q2 20242-$0.96-$0.80-$0.88Q3 20242-$0.90-$0.85-$0.88Q4 20243-$1.01-$0.74-$0.91FY 20249-$3.74-$3.19-$3.50Q1 20253-$0.85-$0.70-$0.77Q2 20254-$0.87-$0.70-$0.79Q3 20254-$0.88-$0.68-$0.75Q4 20254-$0.90-$0.66-$0.78FY 202515-$3.50-$2.74-$3.09Q1 20262-$0.92-$0.92-$0.92Q2 20262-$0.96-$0.89-$0.93Q3 20262-$0.93-$0.61-$0.77Q4 20262-$0.85-$0.61-$0.73FY 20268($3.66)($3.03)($3.35) Replimune Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/13/2025(Estimated)------- 11/12/2024--$0.75-$0.68+$0.07-$0.68--8/8/2024--$0.88-$0.78+$0.10-$0.78-- 5/16/2024Q4 2024-$0.86-$0.82+$0.04-$0.82-- 2/8/2024Q3 2024-$0.89-$0.77+$0.12-$0.77-- 11/7/2023Q2 2024-$0.80-$0.90 -$0.10-$0.90-- 8/3/2023Q1 2024-$0.80-$0.75+$0.05-$0.75-- Get the Latest News and Ratings for REPL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Replimune Group and its competitors with MarketBeat's FREE daily newsletter. 5/18/2023Q4 2023-$0.66-$0.74 -$0.08-$0.74-- 2/9/2023Q3 2023-$0.77-$0.69+$0.08-$0.69-- Replimune Group Earnings - Frequently Asked Questions When is Replimune Group's earnings date? Replimune Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates. Learn more on REPL's earnings history. Did Replimune Group beat their earnings estimates last quarter? In the previous quarter, Replimune Group (NASDAQ:REPL) reported ($0.68) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.75) by $0.07. Learn more on analysts' earnings estimate vs. REPL's actual earnings. How much profit does Replimune Group generate each year? Replimune Group (NASDAQ:REPL) has a recorded net income of -$215.79 million. REPL has generated -$3.05 earnings per share over the last four quarters. What is Replimune Group's EPS forecast for next year? Replimune Group's earnings are expected to grow from ($3.02) per share to ($2.54) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Vir Biotechnology Earnings Date AlloVir Earnings Date Atara Biotherapeutics Earnings Date bluebird bio Earnings Date Beam Therapeutics Earnings Date Bausch Health Companies Earnings Date Vera Therapeutics Earnings Date Kymera Therapeutics Earnings Date MorphoSys Earnings Date Vericel Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report 917 Trades… Zero Losses? (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today This page (NASDAQ:REPL) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Replimune Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Replimune Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
